See the DrugPatentWatch profile for Cellcept
Cellcept is a medication used to prevent organ transplant rejection and treat autoimmune diseases [1]. It contains the active ingredient mycophenolate mofetil [1].
What conditions does Cellcept treat?
Cellcept is primarily prescribed to prevent the body from rejecting a transplanted organ, such as a kidney, liver, or heart [1]. It is also used to manage autoimmune conditions where the body's immune system mistakenly attacks its own tissues. These conditions include certain types of lupus and other autoimmune disorders [1].
How does Cellcept work?
Cellcept works by suppressing the immune system [1]. Specifically, it inhibits the proliferation of lymphocytes, a type of white blood cell that plays a key role in the immune response, including the rejection of foreign tissues like transplanted organs or the attack on the body's own cells in autoimmune diseases [1].
What are the common side effects of Cellcept?
Common side effects associated with Cellcept can include diarrhea, nausea, vomiting, stomach pain, headache, and tremors [1]. It can also increase the risk of infections due to its immunosuppressive nature [1].
When does the patent for Cellcept expire?
Information regarding the patent expiry for Cellcept is available through resources like DrugPatentWatch.com [2]. Specific patent expiry dates can influence the availability of generic versions of the medication.
Can generic versions of Cellcept be made?
Once patents expire, generic manufacturers can typically produce and market their own versions of Cellcept. These generic versions are expected to be bioequivalent to the branded drug but usually come at a lower cost [2].
What are the risks of taking Cellcept?
The risks associated with Cellcept are mainly related to its immunosuppressive effects. This can lead to an increased susceptibility to infections, including serious or opportunistic ones. There is also a potential risk of developing certain types of cancer, particularly skin cancer and lymphoma [1]. Additionally, it carries risks for pregnant women, including potential harm to the fetus [1].
What are alternative treatments for organ transplant rejection or autoimmune diseases?
Alternatives to Cellcept depend on the specific condition being treated. For organ transplant rejection, other immunosuppressants such as tacrolimus, cyclosporine, and sirolimus are used. For autoimmune diseases, treatment options vary widely and can include corticosteroids, azathioprine, methotrexate, and newer biologic therapies, depending on the specific autoimmune condition [1].
Sources:
[1] https://www.drugs.com/cellcept.html
[2] https://drugpatentwatch.com/